Targeting Triple-Negative Breast Cancer Using Allogeneic Stem Cell-Engineered Mesothelin-Specific CAR-NKT Cells with Potent Antitumor Activity

ABSTRACT: Targeting Triple-Negative Breast Cancer Using Allogeneic Stem Cell-Engineered Mesothelin-Specific CAR-NKT Cells with Potent Antitumor Activity

PROVIDER: PRJNA1299401 | ENA |

REPOSITORIES: ENA